Skip to content

Clinical trials

Severe Acute Respiratory Syndrome trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Severe Acute Respiratory Syndrome Country / region: United Kingdom Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
202015
20216
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Unknown status3
Terminated2
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)5
University of Minnesota3
Chelsea and Westminster NHS Foundation Trust2
Imperial College London2
Alexion Pharmaceuticals, Inc.1
AstraZeneca1
Cambridge University Hospitals NHS Foundation Trust1
GlaxoSmithKline1
King's College London1
Portsmouth Hospitals NHS Trust1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Severe Acute Respiratory Syndrome24
COVID-1917
Coronavirus Infections12
Virus Diseases7
RNA Virus Infections6
Coronaviridae Infections5
Nidovirales Infections5
Influenza, Human4
Infections3
Respiratory Distress Syndrome3

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.